See the latest news and media coverage for Clario. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical trial endpoint technology and services provider
clario.comLast updated
In short: Clario was acquired by Thermo Fisher Scientific for $8.875 billion and expanded its clinical trial technologies through strategic acquisitions.
Research in Biological Psychiatry reveals excluding high placebo responders via speech latency boosts drug-placebo separation 2-3 times in brilaroxazine Phase III trial. Clario’s Chief Research Officer Mark Opler co-investigated.
The certification, audited by Schellman, underscores Clario's leadership in responsible AI for clinical trials, complementing ISO 27701 and 27001 standards.
The guidance highlights ArtiQ.Spiro's potential to enable high-quality testing in primary care, expand access, and reduce waiting times.
He received it at the 2025 WLDA Awards Gala for embedding transparency, ethics, and equity in AI systems. His work advances responsible AI in clinical trials.
Nordic, Astorg, Cinven and Novo Holdings closed on the $8.9bn all-cash sale of Clario Holdings to Thermo Fisher Scientific in March.
XROI™ anchors a broader suite of AI-powered solutions designed to elevate leadership performance and organizational impactNEW YORK, April 27, 2026 /PRNewswire/ -- Clario Group today...
Thermo Fisher Scientific raised its 2026 revenue forecast to $47.3-$48.1 billion and adjusted EPS to $24.64-$25.12 after a strong first quarter and the completion of...
BENGALURU: Medical equipment maker Thermo Fisher is nearing an all-cash takeover of US-based Clario in a deal that could value the clinical trial data management...
Track Clario and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.